Skip to main content
. 2017 Apr 19;8(25):40693–40704. doi: 10.18632/oncotarget.17244

Table 2. Summary statistics of the transcriptome sequencing.

Patient Sample type Total reads Mapped reads Total base (bp) Mapped base (bp) Mappping ratio Coverage (X)
P10 T 35,930,408 33,819,287 4,491,301,000 4,227,410,875 94.12% 33
N 34,902,228 32,863,973 4,362,778,500 4,107,996,625 94.16% 32
P14 T 35,315,378 33,125,921 4,414,422,250 4,140,740,125 93.80% 32
N 34,383,802 32,279,443 4,297,975,250 4,034,930,375 93.88% 31
P17 T 35,532,658 33,258,212 4,441,582,250 4,157,276,500 93.60% 32
N 34,537,914 32,152,860 4,317,239,250 4,019,107,500 93.09% 31
P21 T 34,762,386 32,701,011 4,345,298,250 4,087,626,375 94.07% 31
N 35,314,918 33,021,170 4,414,364,750 4,127,646,250 93.50% 32
P24 T 35,610,444 32,509,118 4,451,305,500 4,063,639,750 91.29% 31
N 34,637,398 31,280,461 4,329,674,750 3,910,057,625 90.31% 30
P26 T 34,566,526 32,670,216 4,320,815,750 4,083,777,000 94.51% 31
N 35,384,486 33,407,169 4,423,060,750 4,175,896,125 94.41% 32
P29 T 34,564,642 32,385,294 4,320,580,250 4,048,161,750 93.69% 31
N 34,771,048 32,792,475 4,346,381,000 4,099,059,375 94.31% 32
P36 T 35,371,920 32,571,695 4,421,490,000 4,071,461,875 92.08% 31
N 35,959,532 32,990,753 4,494,941,500 4,123,844,125 91.74% 32
P40 T 42,279,434 39,097,967 5,284,929,250 4,887,245,875 92.50% 38
N 40,083,384 36,852,292 5,010,423,000 4,606,536,500 91.90% 35
Average 35,772,695 33,321,073 4,471,586,847 4,165,134,146 93.17% 32
Total 643,908,506 599,779,317 80,488,563,250 74,972,414,625